EP3965823 - USE OF GOLD NANOCLUSTERS IN TREATING HYPERCHOLESTEROLEMIA OR HYPERCHOLESTEROLEMIA-ASSOCIATED DISEASES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.02.2022 Database last updated on 12.11.2024 | |
Former | The international publication has been made Status updated on 13.11.2020 | Most recent event Tooltip | 28.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Goldred Nanobiotech Co., Ltd. 9F., No. 111-6, Xiyuan Rd. Zhongli Dist. Taoyuan City 320 / TW | For all designated states Yeh, Hung-i 7F.-1, No. 23 Fushun St. Zhongshan Dist. Taipei City, Taiwan 104 / TW | For all designated states Lee, Yi-Nan 2F., No. 381, Sec. 1 Xinshi 1st Rd. Tamsui Dist. New Taipei City, Taiwan 251 / TW | For all designated states Wang, Hsueh-Hsiao 13F., No. 2, Ln. 21, Sec. 6 Xinhai Rd. Wenshan Dist. Taipei City, Taiwan 116 / TW | [2022/11] | Inventor(s) | 01 /
CHANG, Hong-Shong 8F, No.12, Lane 76, Sec.2 Chung-Bei Rd. Chung-Li Tao-Yuan City, Taiwan 320 / CN | 02 /
LI, Kuan-Jung 8F., No.5, Ln. 140, Sec. 3 Linsen Rd. North Dist. Tainan City, Taiwan 704 / CN | 03 /
LAI, Wei-Chung 11F., No.25 Hongshulin Rd. Tamsui Dist. New Taipei City, Taiwan 251 / CN | 04 /
YEH, Hung-i 7F.-1, No. 23 Fushun St. Zhongshan Dist. Taipei City, Taiwan 104 / CN | 05 /
LEE, Yi-Nan 2F., No. 381, Sec. 1 Xinshi 1st Rd. Tamsui Dist. New Taipei City, Taiwan 251 / CN | 06 /
WANG, Hsueh-Hsiao 13F., No. 2, Ln. 21, Sec. 6 Xinhai Rd. Wenshan Dist. Taipei City, Taiwan 116 / CN | [2022/11] | Representative(s) | Lang, Christian LangPatent Anwaltskanzlei IP Law Firm Ingolstädter Straße 5 80807 München / DE | [2022/11] | Application number, filing date | 19928273.2 | 07.05.2019 | [2022/11] | WO2019CN85810 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020223893 | Date: | 12.11.2020 | Language: | EN | [2020/46] | Type: | A1 Application with search report | No.: | EP3965823 | Date: | 16.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application. | [2022/11] | Search report(s) | International search report - published on: | CN | 12.11.2020 | (Supplementary) European search report - dispatched on: | EP | 14.11.2022 | Classification | IPC: | A61K33/242, A61K47/00, A61P3/06, A61K9/00, A61K9/51 | [2022/50] | CPC: |
A61K9/5115 (EP,US);
A61K31/20 (US);
A61K33/242 (EP);
A61K47/6923 (EP);
A61K47/6929 (EP);
A61K9/0019 (EP);
A61P3/06 (EP);
B82Y30/00 (EP,US);
B82Y40/00 (US);
B82Y5/00 (EP,US)
(-)
|
Former IPC [2022/11] | A61K47/00, A61P3/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/11] | Title | German: | VERWENDUNG VON GOLDNANOCLUSTERN ZUR BEHANDLUNG VON HYPERCHOLESTERINÄMIE ODER HYPERCHOLESTERINÄMIE-ASSOZIIERTEN ERKRANKUNGEN | [2022/11] | English: | USE OF GOLD NANOCLUSTERS IN TREATING HYPERCHOLESTEROLEMIA OR HYPERCHOLESTEROLEMIA-ASSOCIATED DISEASES | [2022/11] | French: | UTILISATION DE NANOAGRÉGATS D'OR DANS LE TRAITEMENT DE L'HYPERCHOLESTÉROLÉMIE OU DE MALADIES ASSOCIÉES À L'HYPERCHOLESTÉROLÉMIE | [2022/11] | Entry into regional phase | 18.11.2021 | National basic fee paid | 18.11.2021 | Search fee paid | 18.11.2021 | Designation fee(s) paid | 18.11.2021 | Examination fee paid | Examination procedure | 18.11.2021 | Examination requested [2022/11] | 12.06.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 18.11.2021 | Renewal fee patent year 03 | 20.05.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 | 27.05.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]EP3698787 (MACKAY MEMORIAL HOSPITAL [TW], et al) [E] 1-6,8 * par. 14, 28, 52; claims 2, 6 *; | [A] - CHEN HUI ET AL, "Gold nanoparticles improve metabolic profile of mice fed a high-fat diet", JOURNAL OF NANOBIOTECHNOLOGY, vol. 16, no. 1, doi:10.1186/s12951-018-0338-1, (20181201), page 11, URL: https://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-018-0338-1.pdf, XP055977334 [A] 1-8 * abstract; Table 1; supplemental data * DOI: http://dx.doi.org/10.1186/s12951-018-0338-1 | [A] - Ibrahim Ammal Esmaeel, "Effect of Gold Nanoparticles on Serum Lipid Profile in Albino Mice", OnLine Journal of Biological Sciences, (20180401), pages 432 - 434, URL: https://thescipub.com/pdf/ojbsci.2018.432.434.pdf, (20221102), XP055977253 [A] 1-8 * abstract; p. 433, left col., last par.; Table 1 * | International search | [X]US9101672 (YEH HUNG-I [TW], et al)[X] 1-19 |